SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 43 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $547,000 | +3.4% | 235,967 | +3.6% | 0.00% | – |
Q4 2018 | $529,000 | -84.6% | 227,818 | -1.9% | 0.00% | – |
Q3 2018 | $3,441,000 | +3.6% | 232,226 | +6.2% | 0.00% | – |
Q2 2018 | $3,322,000 | -14.6% | 218,598 | +5.6% | 0.00% | – |
Q1 2018 | $3,888,000 | +362.9% | 207,026 | +347.5% | 0.00% | – |
Q4 2017 | $840,000 | +43.3% | 46,259 | +75.8% | 0.00% | – |
Q3 2017 | $586,000 | – | 26,307 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Wealth Management, LLC | 180,552 | $36,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 122,942 | $24,000 | 0.00% |
CITIGROUP INC | 1,739 | $0 | 0.00% |
GOLDMAN SACHS GROUP INC | 52,553 | $11,000 | 0.00% |
MORGAN STANLEY | 101 | $0 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 15,936 | $3,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 20 | $0 | 0.00% |
BlackRock Inc. | 90,036 | $18,000 | 0.00% |
Ballentine Partners, LLC | 16,700 | $3,000 | 0.00% |
Citadel Advisors | 83,839 | $17,000 | 0.00% |